Ajanta Pharma Ltds Q4 results came a step ahead of Street forecasts but business and logistics disruptions due to the nationwide lockdown may curb growth momentum in FY21.In Q4, US business growth has been reassuring. US generic sales surged 88% year-on-year …
Read More

WP2Social Auto Publish Powered By : XYZScripts.com
Scroll Up